Table 2.
Prevalence of site-specific symptoms by site of infection among MSM and TW in Tijuana, n(%)
| (+) CT/NG Infectiona | (−) CT/NG Infection | |
| Urethral symptoms | ||
| Urethral discharge (n=7) | 3 (42.9) | 4 (57.1) |
| Pain with urination (n=23) | 5 (21.7) | 18 (78.3) |
| Any Urethral symptoms (n=25) | 5 (20.0) | 20 (80.0) |
| Rectal symptoms | ||
| Anorectal pain (n=16) | 3 (18.8) | 13 (81.3) |
| Anorectal discharge (n=9) | 3 (33.3) | 6 (66.7) |
| Anorectal bleeding (n=25) | 5 (20.0) | 20 (80.0) |
| Any anorectal symptoms (n=34) | 7 (20.6) | 27 (79.4) |
| Pharyngeal symptoms | ||
| Sore throat (n=34) | 2 (5.9) | 32 (94.1) |
| (+) Syphilis infection | (−) Syphilis infection | |
| Syphilis symptoms | ||
| Genital ulcer (n=13) | 8 (61.5) | 5 (38.5) |
| Rash (n=15) | 7 (46.7) | 8 (53.3) |
| Any syphilis symptoms (n=26) | 14 (53.9) | 12 (46.2) |
Abbreviations: CT=Chlamydia trachomatis, NG=Neisseria gonorrhoeae, MSM=cisgender men who have sex with cisgender men, TW=transgender women.
*
Row percentages provided.
a
There were 20 CT/NG urethral infections, 37 CT/NG rectal infections, and 18 CT/NG pharyngeal infections with non-missing site-specific symptoms; there were 38 syphilis infections with non-missing symptoms.